Drug intelligence / Profile preview

Neem Mouthrinse

Development stage
Unknown
Lead developer
Medical University of South Carolina
Modality
Small Molecules
Administration
Topical
01

Overview

Neem Mouthrinse is an investigational herbal mouthwash containing an extract of neem leaf (*Azadirachta indica*), developed by the Medical University of South Carolina (MUSC) for the management of radiotherapy-induced oral mucositis. Oral mucositis is a common and debilitating side effect of radiation therapy in head and neck cancer patients, characterized by inflammation and ulceration of the oral mucosa. The therapeutic potential of neem leaf extract in this condition is attributed to its rich content of bioactive compounds, including limonoids like nimbin and azadirachtin, which exhibit potent anti-inflammatory, antioxidant, and antimicrobial activities. The mechanism of action involves the suppression of pro-inflammatory signaling pathways, such as NF-kappaB, and the reduction of oxidative stress, thereby protecting the mucosal lining and promoting healing.

Other names
Neem leaf extractAzadirachta indica leaf extract
02

Targets

NF-κBTNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Neem Mouthrinse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neem Mouthrinse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call